Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,853
Closed -$6K 3100
2025
Q1
$6K Hold
8,853
﹤0.01% 2604
2024
Q4
$7K Hold
8,853
﹤0.01% 2612
2024
Q3
$9K Hold
8,853
﹤0.01% 2504
2024
Q2
$14K Buy
+8,853
New +$13.8K ﹤0.01% 2276
2023
Q2
Sell
-30,256
Closed -$26K 3093
2023
Q1
$26K Sell
30,256
-4,189
-12% -$4.57K ﹤0.01% 2549
2022
Q4
$45K Hold
34,445
﹤0.01% 2467
2022
Q3
$61K Buy
34,445
+546
+2% +$1.36K ﹤0.01% 2375
2022
Q2
$77K Buy
33,899
+3,836
+13% +$9.18K ﹤0.01% 2285
2022
Q1
$99K Sell
30,063
-2,433
-7% -$8.55K ﹤0.01% 2198
2021
Q4
$148K Sell
32,496
-353
-1% -$2.67K ﹤0.01% 2015
2021
Q3
$236K Sell
32,849
-2,023
-6% -$14.8K ﹤0.01% 1933
2021
Q2
$280K Buy
+34,872
New +$294K ﹤0.01% 1918

Other funds holding OCGN

Amalgamated Bank's OCGN Position: Q2 2025 in Review

Amalgamated Bank sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 8,853 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in OCGN in Q2 2021 and held it in 12 quarters. The position peaked at $280K in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

  • Amalgamated Bank reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 8,853 Ocugen shares in Q2 2025, an estimated $6K.
  • Amalgamated Bank first reported a position in Ocugen in Q2 2021 and held it in 12 quarters.
  • Amalgamated Bank's Ocugen position peaked at $280K in Q2 2021.
  • 104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.